Remission of metabolic syndrome: A study of 140 patients six months after Roux-en-Y gastric bypass

Obesity Surgery

Volumn 18, Issue 5, 2008, Pages 601-606

  Rossi, Marçal ^a   Barretto Ferreira Da Silva, Renato ^a   Chaves Alcântara Jr , Geraldo ^a   Regina, Paulo Fernando ^a   Martin Bianco Rossi, Felipe ^b   Serpa Neto, Ary ^b   Zimberg Chehter, Ethel ^b  

^a RR Médicos e Cirurgiões Clinic of Gastroenterology and Obesity Surgery   (Brazil)

^b FACULDADE DE MEDICINA DO ABC   (Brazil)

Author keywords

Bariatric surgery; Gastric bypass; Metabolic syndrome

Indexed keywords

ANTIHYPERTENSIVE AGENT; CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; BODY MASS; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CLINICAL EVALUATION; COMORBIDITY; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MORBID OBESITY; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; REMISSION; RETROSPECTIVE STUDY; RISK FACTOR; STATISTICAL SIGNIFICANCE; STOMACH BYPASS; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT REDUCTION;

BODY MASS INDEX; DIABETES MELLITUS; FEMALE; GASTRIC BYPASS; HUMANS; HYPERTENSION; LIPOPROTEINS, HDL; MALE; METABOLIC SYNDROME X; OBESITY, MORBID; POSTOPERATIVE PERIOD; REMISSION INDUCTION; RETROSPECTIVE STUDIES; TRIGLYCERIDES;

EID: 43049118890     PISSN: 09608923     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11695-008-9468-0     Document Type: Article

References (39)

1. Mokdad AH, Ford ES, Bowman BA, et al. Prevalence of obesity, diabetes and obesity-related health risk factors, 2001. JAMA. 2003;289:76-9.
2. Grundy SM, Brewer HB Jr, Cleeman JI, et al. American Heart Association; National Heart, Lung, and Blood Institute. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation. 2004;109(3):433-8.
3. Kragelund C, Køber L, Faber J, et al. Metabolic syndrome and mortality in stable coronary heart disease: Relation to gender. Int J Cardiol. 2007;121(1):62-7.
4. Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel of Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285:2486-97.
5. Guerrero-Romero F, Rodríguez-Morán M. Concordance between the 2005 International Diabetes Federation definition for diagnosing metabolic syndrome with the National Cholesterol Education Program Adult Treatment Panel III and the World Health Organization definitions. Diabetes Care. 2005;28(10):2588-9.
6. Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004;292:1724-37.
7. Sjostrom L, Lindroos AK, Peltonen M, et al. Swedish Obese Subjects Study Scientific Group. Lifestyle, diabetes and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med. 2004;351:2683-93.
8. Jones KB, Afram JD, Benotti PN, et al. Open versus laparoscopic Roux-en-Y gastric bypass: a comparative study of over 25,000 open cases and the major laparoscopic bariatric reported series. Obes Surg. 2006;16(6):721-7.
9. Lee WJ, Huang MT, Wang W, et al. Effects of obesity surgery on the metabolic syndrome. Arch Surg. 2004;139:1088-92.
10. Case CC, Jones PH, Nelson K, et al. Impact of weight loss on the metabolic syndrome. Diabetes Obes Metab. 2002;4(6):407-14.
11. Madan AK, Orth W, Ternovits CA, et al. Metabolic syndrome: yet another co-morbidity gastric bypass helps cure. Surg Obes Relat Dis. 2006;2(1):48-51.
12. Adami GF, Ravera G, Marinari GM, et al. Metabolic syndrome in severely obese patients. Obes Surg. 2001;11:543-5.
13. Park YW, Zhu S, Palaniappan L, et al. The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med. 2003;163(4):427-36.
14. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA. 2002;287(3):356-9.
15. Ford ES, Giles WH. A comparison of the prevalence of the metabolic syndrome using two proposed definitions. Diabetes Care. 2003;26:575-81.
16. McTigue KM, Harris R, Hemphill B, et al. Screening and interventions for obesity in adults: summary of the evidence for us prevention services task force. Ann Intern Med. 2003;139(11):933-49.
17. Alexandrides TK, Skroubis G, Kalfarentzos F. Resolution of diabetes mellitus and metabolic syndrome following Roux-en-Y gastric bypass and a variant of biliopancreatic diversion in patients with morbid obesity. Obes Surg. 2007;17(2):176-84.
18. Howard BV. Obesity, lipoproteins, and heart disease. Proc Soc Exp Biol Med. 1992;200(2):202-5.
19. Howard BV. Obesity and lipoprotein metabolism: relationship to cardiovascular disease. In: Fletcher GF, Grundy SM, Hayman L, eds. Obesity impact on cardiovascular disease. Armok: Futura Publishing; 1999. p. 155.
20. Tato F, Vega GL, Grundy SM. Determinants of plasma HDL-cholesterol in hypertriglyceridemic patients. Role of cholesterol-ester transfer protein and lecithin cholesteryl acyl transferase. Arterioscler Thromb Vasc Biol. 1997;17(1):56-63.
21. Acuff RV, Cai DJ, Dong ZP, et al. The lipid lowering effect of plant sterol ester capsules in hypercholesterolemic subjects. Lipids Health Dis. 2007;6:11.
22. Busetto L, Sergi G, Enzi G, et al. Short-term effects of weight loss on the cardiovascular risk factors in morbidly obese patients. Obes Res. 2004;12(8):1256-63.
23. Grundy SM. Hypertriglyceridemia, insulin resistance and the metabolic syndrome. Am J Cardiol. 1999;83:25F-9F.
24. Wajchenberg BL. Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocr Rev. 2000;21:697-738.
25. Matsunaga Y. Patophysiology and molecular mechanisms of visceral fat syndrome: the Japanese experience. Diabetes Metab Rev. 1997;13:3-13.
26. Ruderman N, Chisholm D, Pi-Sunyer X, et al. The metabolically obese, normal-weight individual revisited. Diabetes. 1998;47:699-713.
27. Sims EAH. Are there who are obese, but metabolically healthy? Metabolism. 2001;50:1499-504.
28. Goodpaster BH, Krishnhaswami S, Harris TB, et al. Obesity, regional body fat distribution, and the metabolic syndrome in older men and women. Arch Intern Med. 2005;165:777-83.
29. Scopinaro N, Marinari GM, Camerini GB, et al. Specific effects of biliopancreatic diversion on the major components of metabolic syndrome. A long-term follow-up study. Diabetes Care. 2005;28:2406-11.
30. Egger G. The case for using waist to hip ratio measurements in routine medical checks. Med J Aust. 1992;156:280-5
31. Fujimoto WY, Bergstrom RW, Bokyo EJ, et al. Visceral adiposity and incident coronary heart disease in Japanese-American men. Diabetes Care. 1999;22:1808-12.
32. Lerário DD, Gimeno SG, Franco LJ, et al. Weight excess and abdominal fat in the metabolic syndrome among Japonese-Brazilians. Rev Saúde Publica. 2002;36:4-11.
33. Smith U. Impaired ("diabetic") insulin signaling and action occur in fat cells long before glucose intolerance-is insulin resistance initiated in the adipose tissue? Int J Obes. 2002;26:897-904.
34. Cummings DE, Weigle DS, Frayo RS, et al. Human plasma ghrelin levels after diet-induced weight loss and gastric bypass surgery. N Engl J Med. 2002;346(21):1623-30.
35. Valverde I, Puente J, Martin-Duce A, et al. Changes in glucagon-like peptide 1 (GLP-1) secretion after biliopancreatic diversion or vertical banded gastroplasty in obese subjects. Obes Surg. 2005;15:387-97.
36. Baggio LL, Drucker DJ. Glucagon-like peptide-1 and glucagon-like peptide-2. Best Pract Res Clin Endocrinol Metab. 2004;18:531-54.
37. Polyzogopoulou EV, Kalfarentzos F, Vagenakis AG, et al. Restoration of euglycemia and normal acute insulin response to glucose in obese subjects with type 2 diabetes following bariatric surgery. Diabetes. 2003;52:1098-103.
38. Stevens VJ, et al, for the Trials of Hypertension Prevention Research Group. Long-term weight loss and changes in blood pressure: results of trials of hypertension prevention, phase II. Ann Intern Med. 2001;134:1-11.
39. Landsberg L. Weight reduction and obesity. Clin Exp Hypertens. 1999;21:763-8.